HIGHLIGHTS
- who: Yongfang Yao and collaborators from the Nanjing, China have published the paper: State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer, in the Journal: (JOURNAL)
- what: In this review, we have discussed the latest staging and treatment strategies of advanced-stage NSCLC.
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Lung cancer has become one of the most widespread and deadliest . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.